Linked Life Data

9186347

Source:http://linkedlifedata.com/resource/pubmed/id/9186347

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-7-14
pubmed:abstractText
We evaluated the prognostic impact of neuroendocrine differentiation in prostate cancer with regard to the onset of endocrine therapy failure.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-5347
pubmed:author
pubmed:issnType
Print
pubmed:volume
158
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
171-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9186347-Adenocarcinoma, pubmed-meshheading:9186347-Aged, pubmed-meshheading:9186347-Aged, 80 and over, pubmed-meshheading:9186347-Antineoplastic Agents, Hormonal, pubmed-meshheading:9186347-Cell Differentiation, pubmed-meshheading:9186347-Disease Progression, pubmed-meshheading:9186347-Disease-Free Survival, pubmed-meshheading:9186347-Flutamide, pubmed-meshheading:9186347-Follow-Up Studies, pubmed-meshheading:9186347-Gonadotropin-Releasing Hormone, pubmed-meshheading:9186347-Humans, pubmed-meshheading:9186347-Male, pubmed-meshheading:9186347-Middle Aged, pubmed-meshheading:9186347-Multivariate Analysis, pubmed-meshheading:9186347-Neurosecretory Systems, pubmed-meshheading:9186347-Orchiectomy, pubmed-meshheading:9186347-Prognosis, pubmed-meshheading:9186347-Proportional Hazards Models, pubmed-meshheading:9186347-Prostatic Neoplasms, pubmed-meshheading:9186347-Retrospective Studies
pubmed:year
1997
pubmed:articleTitle
The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy.
pubmed:affiliation
Department of Pathology, Erasmus University, Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article